Bausch & Lomb, Allergan go Forward

Eye-care company Bausch & Lomb will implement Phase Forward's InForm electronic data capture solution and Allergan has also signed on with the integrated data management solution supplier.

For Bausch & Lomb, the implementation is corporate wide, encompassing all trials. The eye-care company will use the InForm system in conjunction with the Central Coding module, integrated with the EDC system to help users streamline the coding of medical terms by automating manual coding tasks and increasing consistency.

And Allergan, the discoverer and developer of pharmaceuticals, biologics and medical devices, has signed a multi-year, multi-million-dollar deal making Phase Forward its EDC supplier. The Allergan announcement was made by Phase Forward in conjunction with its third-quarter results, which marked its 21st consecutive quarter of growth since its IPO five years ago.

- here's the Bausch & Lomb release
- see the Q3 financial results release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.